Investor profile
University of Cambridge Enterprise has backed 6 European tech companies across 6 funding rounds between 2019 and 2023, joining rounds totalling €22M. Most active in Healthtech and AI. Data as of 7 Aug 2026.
Also recorded as: The University of Cambridge Enterprise Fund
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| PredictImmune | UK | 1 | €11M |
| PolyProx Therapeutics | UK | 1 | €4.0M |
| Xampla | UK | 1 | €2.3M |
| PharmEnable | UK | 1 | €2.1M |
| RoboK | UK | 1 |
| Company | Stage | Amount | Date |
|---|---|---|---|
| PredictImmune | Series B | €11M | 2019-07 |
| PolyProx Therapeutics | Seed | €4.0M | 2019-04 |
| Xampla | Seed | €2.3M | 2020-04 |
| PharmEnable |
| €1.9M |
| Qkine | UK | 1 | €641k |
| Seed |
| €2.1M |
| 2020-01 |
| RoboK | Other | €1.9M | 2023-06 |
| Qkine | Seed | €641k | 2019-04 |
